Financial statements Biotechnika
Balance sheet data of BIOTECHNIKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 37 459,77 | 52 338,08 | 232 109,15 | 286 493,32 | 70 666,74 | 66 579,78 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 37 459,77 | 52 338,08 | 232 109,15 | 286 493,32 | 70 666,74 | 66 579,78 |
| C. Share capital contributions (basic funds) | - | - | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 37 459,77 | 52 338,08 | 232 109,15 | 286 493,32 | 70 666,74 | 66 579,78 |
| A. Equity | -27 745,50 | 10 972,38 | 43 025,61 | 83 952,42 | 40 911,33 | 40 187,69 |
| B. Liabilities and provisions for liabilities | 65 205,27 | 41 365,70 | 189 083,54 | 202 540,90 | 29 755,41 | 26 392,09 |
| I. Long-term liabilities | - | - | - | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | - | - | - | 202 540,90 | 29 755,41 | 26 392,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.